MICHEAL MACKEN: Open Payments
NPI 1336110550 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$133,992 in 179 payments from 5 companies in 2025. Trend: 2023 $82,956 · 2024 $116,178 · 2025 $133,992
Speaker / faculty: $94,365Travel & lodging: $18,328Consulting: $13,500Food & beverage: $3,949Honoraria: $3,850
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 110 | $73,507 |
| LivaNova USA, Inc. | 45 | $39,789 |
| JAZZ PHARMACEUTICALS INC. | 16 | $13,906 |
| SK Life Science, Inc. | 5 | $3,852 |
| UCB SA | 3 | $2,938 |
Products named: Fintepla, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, EPIDIOLEX, VNS Therapy, Nayzilam, XCOPRI.
Industry payments across CO — which companies pay providers there.
